Regeneron Pharmaceuticals, Inc.

Norinchukin Bank, The REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

9,632

Value ($000)

7,435

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	7,435	0.1%	9,632	12/31/2025
2025 Q3	11/14/2025	4,954	0.1%	8,811	9/30/2025
2025 Q2	8/14/2025	4,806	0.1%	9,154	6/30/2025
2025 Q1	5/14/2025	5,314	0.1%	8,378	3/31/2025
2024 Q4	2/13/2025	4,139	0.1%	5,810	12/31/2024
2024 Q3	11/14/2024	5,608	0.1%	5,335	9/30/2024
2024 Q2	8/14/2024	4,838	0.1%	4,603	6/30/2024
2024 Q1	5/14/2024	4,400	0.1%	4,571	3/31/2024
2023 Q4	2/13/2024	4,134	0.1%	4,707	12/31/2023
2023 Q3	11/13/2023	4,423	0.1%	5,375	9/30/2023
2023 Q2	8/14/2023	7,893	0.1%	10,985	6/30/2023
2023 Q1	5/12/2023	6,916	0.1%	8,417	3/31/2023
2022 Q4	2/13/2023	5,913	0.1%	8,196	12/31/2022
2022 Q3	11/14/2022	6,926	0.1%	10,054	9/30/2022
2022 Q2	8/10/2022	5,366	0.1%	9,077	6/30/2022
2022 Q1	5/12/2022	7,708	0.1%	11,036	3/31/2022
2021 Q4	2/10/2022	6,297	0.1%	9,971	12/31/2021
2021 Q3	11/9/2021	6,356	0.1%	10,502	9/30/2021
2021 Q2	8/11/2021	5,522	0.1%	9,886	6/30/2021
2021 Q1	5/12/2021	4,616	0.1%	9,756	3/31/2021
2020 Q4	2/12/2021	4,489	0.1%	9,291	12/31/2020
2020 Q3	11/12/2020	5,207	0.1%	9,302	9/30/2020
2020 Q2	8/12/2020	5,421	0.1%	8,693	6/30/2020
2020 Q1	5/13/2020	3,442	0.1%	7,050	3/31/2020
2019 Q4	2/12/2020	4,094	0.1%	10,903	12/31/2019
2014 Q2	7/31/2014	840	0.0%	2,973	6/30/2014
2014 Q1	5/13/2014	978	0.0%	3,258	3/31/2014
2013 Q4	2/14/2014	808	0.0%	2,934	12/31/2013